Sidhu’s latest SPAC, dubbed JATT III Acquisition, listed on the Nasdaq this morning via a $60 million IPO. The company is ...

This year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest victim.

Phase 2 data on Spyre Therapeutics’ anti-TL1A antibody SPY072 in rheumatoid arthritis have fallen short of expectations, ...

Hansoh Pharmaceutical has offered a bullish assessment of China’s innovative biopharma sector, arguing (PDF) that the ...

The FDA has approved Abbott’s first-of-its-kind bio-wearable sensor that can warn diabetics of increased ketones that can ...

Charles River Laboratories (CRL) and Taiwan-based Medigen Vaccine Biologics are teaming up to prep Medigen’s multivalent ...

SK became an epilepsy player in its own right when it scored FDA approval for Xcopri in 2019 as a treatment for treat partial ...

The skyrocketing use of Chinese biopharmas as a source of innovation for U.S. drug developers has been viewed with alarm ...

Roche has taken its obesity strategy into uncharted territory via a $190 million upfront payment for a clinical-stage UCN2 ...

A new report on the health of the Massachusetts biotech scene has painted a mixed picture of how drug developers are faring ...

The FDA has put a clinical hold on Regenxbio’s RGX-121 over asymptomatic spine MRI findings, derailing the biotech’s plans to ...

Roche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic.  | Roche and Eli Lilly have won ...